Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score ‐matched survival analysis
ConclusionsCompared with surgical resection alone, postoperative adjuvant PVC treatment boosts survival and reduces early tumor recurrences in patients surgically treated for HCC and PVTT.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Yang Gao,
Peng ‐Xiang Wang,
Jian‐Wen Cheng,
Yun‐Fan Sun,
Bo Hu,
Wei Guo,
Kai‐Qian Zhou,
Yue Yin,
Yuan‐Cheng Li,
Jian Wang,
Jun‐Feng Huang,
Shuang‐Jian Qiu,
Jian Zhou,
Jia Fan,
Xin‐Rong Yang Tags: ORIGINAL RESEARCH Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Hepatocellular Carcinoma | Liver Cancer | Perfusion | Study | Thrombosis